Product Information

SAXAGLIPTIN HCL 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.1086 per EA under NDC 65862082690. Its NADAC has been published 51 times since Dec 3, 2025.

FDA first approved this application on Jul 31, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SAXAGLIPTIN HCL 5 MG TABLET

Saxagliptin
$1.1086per EA

Strength

5 mg/1

NDC

65862082690

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SAXAGLIPTIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205972

FDA Approved

7/31/2023

TE Code

AB

On Market Since

7/31/2023

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for SAXAGLIPTIN HCL 5 MG TABLET has been published 51 times since Dec 3, 2025, and over the history we have for it it has declined 61.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1086 per EA
All-time high$2.9076 (Dec 10, 2025)
All-time low$1.0387 (Sep 23, 2026)
52-week high$2.9076
52-week low$1.0387
Median price$1.1412
Average price$1.4479
Largest weekly change-25.9% (Feb 18, 2026)
Weeks tracked51
Tracking sinceDec 3, 2025

Price History

1W

+3.8%

1M

+6.7%

3M

+5.6%

6M

-2.9%

1Y

N/A

3Y

N/A

5Y

N/A

All

-61.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SAXAGLIPTIN HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN HCL 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.1086 per EA (NDC 65862082690), effective Nov 18, 2026.

How has the price of SAXAGLIPTIN HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SAXAGLIPTIN HCL 5 MG TABLET has declined 61.9%. It has been tracked across 51 weekly CMS publications since Dec 3, 2025.

What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN HCL 5 MG TABLET?

Since Dec 3, 2025, the NADAC for SAXAGLIPTIN HCL 5 MG TABLET has ranged from a low of $1.0387 (Sep 23, 2026) to a high of $2.9076 (Dec 10, 2025), with a median of $1.1412 per EA.

Are there cheaper alternatives to SAXAGLIPTIN HCL 5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SAXAGLIPTIN HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures SAXAGLIPTIN HCL 5 MG TABLET?

SAXAGLIPTIN HCL 5 MG TABLET (NDC 65862082690) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.